INTRODUCTION {#S1}
============

DNA double-strand breaks (DSBs) are genotoxic lesions that threaten genomic integrity. The failure to repair DSBs has deleterious consequences, leading to chromosomal translocations and genomic instability that can progress to cell death or neoplastic transformation ([@R1]; [@R38]). In mammalian cells, the DNA damage response (DDR) pathway senses, signals, and repairs the damage by activating multiple DNA checkpoint and repair pathways ([@R16]; [@R55]). In mammalian cells, DSBs are repaired primarily by classical non-homologous end joining (C-NHEJ), homologous recombination (HR), or alternative non-homologous end joining (A-NHEJ) repair pathways. C-NHEJ repairs DSBs through direct ligation of the broken DNA ends, with little or no end processing, and thus is error prone ([@R52]). In contrast, HR uses homologous sister chromatids as templates to repair the break in an error-free manner and is initiated by extensive nucleolytic processing of the 5′ end of a DSB by DNA end resection ([@R37]; [@R40]; [@R80]). A-NHEJ repair is initiated by limited end resection and involves some of the same factors that comprise the HR end resection machinery ([@R75]; [@R83]). DNA end resection generates 3′ single-stranded DNA (ssDNA), which, if not removed by endonucleases, mitigates the activation of the ataxia-telangiectasia mutated-checkpoint kinase 2 (ATM-CHK2) checkpoint pathway that inhibits C-NHEJ repair ([@R37]; [@R52]). ssDNA overhangs are further sensed and bound by replication protein A (RPA) to recruit ATR interacting protein (ATRIP) and ATR to damage sites ([@R18]; [@R103]). RAD17 loads the RAD9-RAD1-HUS1 (9-1-1) complex to ssDNA to activate ATR-mediated CHK1 phosphorylation, which initiates cell-cycle arrest and DNA repair ([@R17]; [@R39]; [@R47]; [@R104]). Similar to resected ssDNA, stalled DNA replication forks possess regions of ssDNA that potently activate ATR-CHK1 by coordinating components of the replisome complex, including Claspin, AND-1, Timeless, and Tipin. These factors recruit CHK1 to ssDNA to enable CHK1 activation by ATR so as to maintain genome stability ([@R15]; [@R34]; [@R41]; [@R45]; [@R54]).

Another mediator of genome stability is telomeres, repetitive DNA-protein complexes that are protected from inappropriately activating DNA DDR checkpoints by a complex of six core telomere-specific-binding proteins called shelterin ([@R21]). The duplex telomere-binding proteins TRF1 and TRF2-RAP1 and the single-stranded telomere DNA-binding protein POT1 (POT1a/b in mice) are integral members of this complex. POT1 forms a heterodimer with TPP1, and TIN2 tethers POT1-TPP1 to TRF1 and TRF2 ([@R90]). The targeted removal of specific shelterin components leads to uncapped chromosome ends that are recognized as DSBs, revealing that unique members of this complex evolved to protect telomeres from engaging in specific DNA repair pathways. In eukaryotes, the MRE11-RAD50-NBS1 (MRN) complex is the primary sensor of DSBs. Deletion of TRF2 in the G1 phase of the cell cycle activates MRN-ATM-CHK2-dependent C-NHEJ-mediated repair ([@R2]; [@R12]; [@R23]; [@R24]). Removal of TRF2 and POT1a/b-TPP1 activates ATR-CHK1-dependent A-NHEJ-mediated repair ([@R4]; [@R22]; [@R33]; [@R42]; [@R44]; [@R64]; [@R74]). In addition, the removal of RAP1 together with the basic domain of TRF2 leads to rapid telomere attrition and formation of end-to-end chromosome fusions due to the activation of HR-mediated repair ([@R14]; [@R66]). We recently showed that the interaction of NBS1 with TRF2 dictates the telomere repair pathway choice ([@R67]). The C-NHEJ-mediated repair of telomeres lacking TRF2 requires phosphorylated NBS1 at serine 432 (NBS1^S432^) to activate ATM, while the interaction of de-phosphorylated NBS1^S432^ with TRF2 promotes the A-NHEJ repair of telomeres lacking POT1a/b-TPP1. In addition, immediately after DNA replication, TRF2 recruits the Apollo/SNM1B nuclease to resect the leading C-strand telomere to generate a short 3′ overhang ([@R13]; [@R46]; [@R67]; [@R91]). Further resection by EXO1 generates longer overhangs that are inhibitory to NHEJ repair but favor HR ([@R42]; [@R91], [@R92]).

Due to their highly repetitive nature and their propensity to adopt aberrant secondary structures, including G-quadru-plexes, telomeres represent significant challenges for the replication machinery ([@R86]). TRF1 helps to address this problem by recruiting Timeless, a component of the replisome fork protection complex, to telomeres to prevent replication fork stalling ([@R50]). However, how the replisome contributes to the repair of damaged DNA is not known. In the present study, we uncover telomere sensing and repair roles engaged by components of the replisome Claspin, Proliferating cell nuclear antigen (PCNA), and Downstream neighbor of SON (DONSON) (CPD). CPD promotes A-NHEJ-mediated repair of dysfunctional telomeres lacking POT1-TPP1 or TRF2-POT1-TPP1 in an MRN- and ATR-ATRIP-independent manner, demonstrating that MRN is not absolutely required for A-NHEJ repair. In the absence of MRN, DNA-PK~cs~ is required to promote CHK1 phosphorylation and A-NHEJ repair. In addition, we show that TRF2 directly interacts with Claspin and, in conjunction with DONSON, promotes the recruitment of EXO1 and CTIP to newly replicated telomeres to mediate C-strand resection and telomere end protection. Our work highlights the contribution of the replisome in mediating the repair of dysfunctional telomeres.

RESULTS {#S2}
=======

The A-NHEJ Pathway Repairs Telomeres Lacking TRF2 and POT1-TPP1 in an MRN-Independent Manner {#S3}
--------------------------------------------------------------------------------------------

We and others have previously shown that C-NHEJ-mediated repair of telomeres devoid of TRF2 requires functional MRN ([@R2]; [@R23]; [@R24]). To explore the requirement of the MRN complex in the repair of telomeres lacking shelterin components, we removed POT1a/b-TPP1, TRF2, and POT1a/b-TPP1 or TRF2-TIN2 in WT or *Nbs1* null cell lines. More than 60% of WT mouse embryonic fibroblasts (MEFs) exhibited γ-H2AX or 53BP1^+^ dysfunctional telomere-induced foci (TIFs) after the removal of POT1a/b-TPP1 with the dominant negative TPP1^ΔRD^ allele ([Figures S1A](#SD1){ref-type="supplementary-material"} and [S1B](#SD1){ref-type="supplementary-material"}) ([@R23]; [@R33]; [@R36]; [@R64], [@R65], [@R67]; [@R94]). Similar treatment of *Nbs1*^−/−^ MEFs or human *NBS-ILB1* cells lacking functional NBS1 ([@R27]; [@R60]) resulted in \~30% of cells displaying TIFs. A similar number of TIFs were observed in both WT and *Nbs1*^−/−^ MEFs lacking both TRF2 and POT1a/b-TPP1 ([Figures S1A](#SD1){ref-type="supplementary-material"} and [S1B](#SD1){ref-type="supplementary-material"}). These results indicate that the DDR is not abrogated at telomeres lacking POT1a/b-TPP1 in the absence of functional MRN.

We next examined the number of telomere fusions in *Nbs1*^−/−^ MEFs to distinguish between C-NHEJ chromosome fusions stemming from the depletion of TRF2 from A-NHEJ or HR-mediated chromosome fusions stemming from the loss of POT1-TPP1. As expected, only \~6% of telomeres lacking TRF2 were fused in MEFs lacking *Nbs1*. In contrast, the removal of POT1-TPP1 from WT or *Nbs1*^−/−^ MEFs or *NBS-ILB1* cells generated fusions involving \~15% of all chromosomes, accompanied by robust CHK1 phosphorylation ([Figures 1A](#F1){ref-type="fig"}--[1C](#F1){ref-type="fig"}). In WT MEFs lacking both TRF2 and POT1a/b-TPP1, 80% of all chromosomes were fused, while in *Nbs1*^−/−^ MEFs or *NBS-ILB1* cells, these fusions decreased to involve \~40% of chromosomes ([Figures 1A](#F1){ref-type="fig"}--[1C](#F1){ref-type="fig"}). Comparable numbers of chromosome fusions (30%--40%) were observed in *Nbs1*^−/−^ MEFs lacking TRF2-TIN2 ([@R36]). Similar phenotypes were observed in *Nbs1*^−/−^ MEFs expressing TRF2^ΔBΔM^ and small hairpin *Tpp1* (sh*Tpp1*) ([Figures S1C](#SD1){ref-type="supplementary-material"} and [S1D](#SD1){ref-type="supplementary-material"}). Chromosome orientation-fluorescence *in situ* hybridization (CO-FISH) ([@R5]) revealed that chromosomal fusions lacking both TRF2 and POT1a/b-TPP1 took place in G1 phase of the cell cycle, with a small percentage of G2 chromosome and sister chromatid fusions that occurred post-replicatively ([@R46]) ([Figure S1E](#SD1){ref-type="supplementary-material"}). These observations indicate that telomeric ends lacking both TRF2 and POT1-TPP1 are efficiently repaired in an MRN-independent manner and that this MRN-independent pathway also repairs \~50% of all dysfunctional telomeres lacking both TRF2 and POT1-TPP1 in WT cells. In agreement with previously published results ([@R95]), treatment of *Nbs1*^−/−^ MEFs with 2 Gy ionizing radiation (IR) also promoted the accumulation of 53BP1 and γ-H2AX to genomic DSBs, accompanied by an increase in the number of genomic chromosomal fusions ([Figures S1F](#SD1){ref-type="supplementary-material"}--[S1H](#SD1){ref-type="supplementary-material"}). These results are indicative of a role for MRN-independent repair of both telomeres lacking POT1-TPP1, TRF2, and POT1-TPP1, as well as IR-induced damaged DNA.

We next determined which DNA repair pathways are involved in the MRN-independent repair of telomeres lacking both TRF2 and POT1a/b-TPP1. shRNA-mediated depletion of factors involved in A-NHEJ, including ligase III ([@R3]; [@R64]; [@R74]; [@R88]), polymerase q encoded by *Polq* ([@R11]; [@R58], [@R59]; [@R74]), and poly (ADP-ribose) polymerase-1 (PARP1) ([@R3]; [@R74]), reduced chromosomal fusions by 3- to 5-fold ([Figures 1D](#F1){ref-type="fig"} and [1E](#F1){ref-type="fig"}). In contrast, the depletion of Rad51 and Rad52, which are known to play an important role in HR and break-induced repair (BIR), respectively ([@R78]; [@R87]), did not appreciably reduce the number of chromosomal fusions ([Figures 1D](#F1){ref-type="fig"} and [1E](#F1){ref-type="fig"}). We therefore conclude that the repair of dysfunctional telomeres that are devoid of TRF2 and POT1a/b-TPP1 is mediated by MRN-independent A-NHEJ and does not involve C-NHEJ, HR, or BIR pathways.

Replisome Components Claspin, DONSON, and PCNA Localize to Dysfunctional Telomeres Lacking Both TRF2 and POT1-TPP1 {#S4}
------------------------------------------------------------------------------------------------------------------

We found that the accumulation of ssDNA damage sensor protein RPA at IR-induced DNA damaged foci was reduced by \~80% in the absence of NBS1 ([Figure S1F](#SD1){ref-type="supplementary-material"}), which supports previously published reports demonstrating that in the absence of functional MRN, RPA localized poorly to damaged ssDNA, preventing the activation of ATR and downstream damage signaling ([@R39]; [@R57]; [@R79]; [@R99]). Similarly, in *Nbs1*^−/−^ MEFs lacking POT1a/b-TPP1 or TRF2 and POT1a/b-TPP1, neither phosphorylated RPA32 (p-RPA32), ATRIP, nor the HR repair protein RAD51 were found to localize to dysfunctional telomeres ([Figures 2A](#F2){ref-type="fig"}, [2B](#F2){ref-type="fig"}, and [S2A](#SD1){ref-type="supplementary-material"}). p-RPA32 and ATRIP^+^ TIFs were detected on dysfunctional telomeric ends only after the reconstitution of *NBS-ILB1* cells with WT NBS1 ([Figures 2A](#F2){ref-type="fig"}, [2B](#F2){ref-type="fig"}, [S2B](#SD1){ref-type="supplementary-material"}, and [S2C](#SD1){ref-type="supplementary-material"}). These results further support the observation that in the absence of functional MRN, telomeres lacking both TRF2 and POT1a/b-TPP1 are not repaired by HR. In addition, failure to detect p-RPA32 and ATRIP at these telomeres suggest that ATR is unlikely to be the kinase that phosphorylates CHK1 at these dysfunctional telomeres.

We therefore searched for proteins that mediate both CHK1 activation and DNA repair and identified Claspin, an integral component of the replisome complex ([@R26]) and an adaptor protein previously shown to mediate CHK1 phosphorylation after DNA damage ([@R15]; [@R45]; [@R54]). Using the Fucci system, which uses the fluorescent G1 reporter CDT1 and the S/G2 reporter Geminin ([@R72]), we found that Claspin preferentially localizes to the nuclei in S/G2 phases of the cell cycle ([Figure S2D](#SD1){ref-type="supplementary-material"}) and interacts with a large number of proteins involved in DNA repair and replication ([@R77]). Co-immunoprecipitation (Co-IP) experiments revealed that Claspin directly interacts with several replisome components, including PCNA and DONSON ([Figure 2C](#F2){ref-type="fig"}) ([@R69]; [@R96], [@R97]). Claspin has been shown to recognize and bind to branched/forked DNA structures containing both double-stranded and ssDNA ([@R48]; [@R73]). *In vitro* DNA-binding assays reveal that Claspin binds to a variety of ssDNAs, including telomeric G-rich oligos, telomeric C-rich oligos, and oligo-dT ([Figures S2E](#SD1){ref-type="supplementary-material"} and [S2F](#SD1){ref-type="supplementary-material"}). While individual endogenous or epitope-tagged Claspin, PCNA, and DONSON (abbreviated CPD) components localized poorly to dysfunctional telomeres lacking POT1a/b-TPP1 or TRF2 and POT1a/b-TPP1 in WT or *Nbs1*^−/−^ MEFs ([Figures 2D](#F2){ref-type="fig"}--[2G](#F2){ref-type="fig"}, [S2G](#SD1){ref-type="supplementary-material"}, and [S2H](#SD1){ref-type="supplementary-material"}), co-expression of any 2 replisome components stabilized complex formation and resulted in a 4-fold increase in CPD localization at both functional and dysfunctional telomeres in U2OS cells ([Figures 2H](#F2){ref-type="fig"} and [S2I](#SD1){ref-type="supplementary-material"}). shRNA-mediated depletion of any individual CPD component resulted in the instability of the other 2 proteins, suggesting that complex formation promotes CPD stability ([Figure S2J](#SD1){ref-type="supplementary-material"}). Finally, bromodeoxyuridine (BrdU)-labeling experiments in U2OS cells revealed that CPD readily co-localized with BrdU to newly replicated telomeres ([Figures 2I](#F2){ref-type="fig"} and [S2K](#SD1){ref-type="supplementary-material"}).

CPD Promotes A-NHEJ-Mediated Repair of Telomeres Lacking Both TRF2 and POT1a/b-TPP1 {#S5}
-----------------------------------------------------------------------------------

shRNA-mediated depletion of any of the CPD components individually in WT MEFs lacking both TRF2 and POT1a/b-TPP1 resulted in a \~50% reduction in the number of γ-H2AX^+^ TIFs and end-to-end chromosome fusions observed, revealing that CPD participates in the A-NHEJ-mediated repair of dysfunctional telomeres ([Figures 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}). In both *Nbs1*^−/−^ MEFs and *NBS-ILB1* cells lacking POT1a/b-TPP1, depleting CPD components individually reduced the number of γ-H2AX or 53BP1^+^ TIFs as well as end-to-end telomere fusions by \~3- to 5-fold without adversely affecting cell-cycle profiles, indicating that CPD plays critical roles in the sensing and repair of these dysfunctional telomeric ends independent of MRN function ([Figures 3A](#F3){ref-type="fig"}--[3C](#F3){ref-type="fig"} and [S3A](#SD1){ref-type="supplementary-material"}--[S3F](#SD1){ref-type="supplementary-material"}). CPD also plays a role in the HR-mediated repair of telomeres lacking POT1a/b-TPP1, since Rad51 localization and telomere sister chromatid exchanges (T-SCEs), both hallmarks of HR-mediated repair, were reduced by 3- to 4-fold in the absence of CPD ([Figures S3G](#SD1){ref-type="supplementary-material"} and [S3H](#SD1){ref-type="supplementary-material"}). In contrast, CPD is not involved in the C-NHEJ repair of telomeres lacking TRF2 ([Figures 3B](#F3){ref-type="fig"}, [3C](#F3){ref-type="fig"}, and [S3B](#SD1){ref-type="supplementary-material"}--[S3D](#SD1){ref-type="supplementary-material"}).

Claspin contains several functional domains, including a PCNA-interacting protein motif (PIP) near its N terminus and a CHK1-binding domain (CKBD) along with an acidic patch (AP) in its C terminus ([Figure 3D](#F3){ref-type="fig"}) ([@R77]; [@R97]). Phosphorylation of the AP by CDC7 prevents the intramolecular interaction of Claspin, promoting its binding to PCNA and DNA substrates ([@R97]). Three phosphorylation sites in the CKBD domain of Claspin and the mutation of these to al-anines (the Claspin^3A^ mutant) abolished the ability of Claspin to promote TIF formation, end-to-end chromosome fusions, and CHK1 phosphorylation ([Figures 3E](#F3){ref-type="fig"}--[3G](#F3){ref-type="fig"}, [S3I](#SD1){ref-type="supplementary-material"}, [S3J](#SD1){ref-type="supplementary-material"}, [S4A](#SD1){ref-type="supplementary-material"}, and [S4B](#SD1){ref-type="supplementary-material"}) ([@R54]). The number of TIFs, chromosome fusions, and CHK1 phosphorylations was almost fully restored when shRNA-resistant WT Claspin but not the Claspin^3A^ mutant was reconstituted into *Nbs1*^−/−^ MEFs lacking TRF2-POT1a/b-TPP1 ([Figures 3E](#F3){ref-type="fig"}--[3G](#F3){ref-type="fig"}, [S3I](#SD1){ref-type="supplementary-material"}, [S3J](#SD1){ref-type="supplementary-material"}, [S4A](#SD1){ref-type="supplementary-material"}, and [S4B](#SD1){ref-type="supplementary-material"}), revealing that Claspin-mediated CHK1 phosphorylation is essential for the A-NHEJ repair of telomeres lacking POT1a/b-TPP1. We also found that the Claspin N terminus (Claspin^N-Ter^) interacts with PCNA, while the C terminus (Claspin^C-Ter^) interacts with DONSON ([Figures 3H](#F3){ref-type="fig"} and [S4C](#SD1){ref-type="supplementary-material"}). Claspin^3A^ and Claspin^C-Ter^ but not Claspin^N-Ter^ are able to co-localize with GFP-DONSON on telomeres, but only Claspin^C-Ter^ promotes CHK1 phosphorylation ([Figures 3I](#F3){ref-type="fig"}, [S4B](#SD1){ref-type="supplementary-material"}, and [S4D](#SD1){ref-type="supplementary-material"}). Depletion of CPD individually abolished TIF formation, chromosome fusion, and CHK1 phosphorylation in *Nbs1*^−/−^ MEFs lacking both TRF2 and POT1a/b/TPP1, and only the expression of WT CPD rescued these phenotypes ([Figures 3E](#F3){ref-type="fig"}--[3G](#F3){ref-type="fig"}, [3J](#F3){ref-type="fig"}, [3K](#F3){ref-type="fig"}, [S4B](#SD1){ref-type="supplementary-material"}, and [S4D](#SD1){ref-type="supplementary-material"}--[S4I](#SD1){ref-type="supplementary-material"}). These results suggest that CPD is required for A-NHEJ repair at dysfunctional telomeres lacking both TRF2 and POT1a/b-TPP1 by promoting CHK1 phosphorylation in an MRN-independent manner.

DNA-PK~cs~ Is Required for MRN-Independent CHK1 Phosphorylation {#S6}
---------------------------------------------------------------

In the absence of functional MRN, telomeres lacking both TRF2 and POT1a/b-TPP1 fail to recruit RPA, ATRIP, and RAD51, suggesting that ATR-ATRIP cannot phosphorylate CHK1 at these telomeres ([Figures 2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}). Since expression of the Claspin^3A^ mutant reduced both CHK1 phosphorylation and the A-NHEJ repair of dysfunctional telomeres in *Nbs1*^−/−^ MEFs ([Figures 3E](#F3){ref-type="fig"}--[3G](#F3){ref-type="fig"} and [S4B](#SD1){ref-type="supplementary-material"}), our data suggest that Claspin-mediated phosphorylation of CHK1 is required for A-NHEJ repair of dysfunctional telomeres in the absence of functional MRN. In support of this observation, Claspin has been shown to participate in ATR-independent phosphorylation of CHK1 ([@R45]; [@R71]). Previous studies also reveal that DNA-dependent protein kinase (DNA-PK~cs~), a key regulator of C-NHEJ repair, is required to maintain Claspin-CHK1 complex stability and is activated by DSBs in the absence of functional MRN ([@R35]; [@R53]). We postulated that DNA-PK~cs~ may participate in the phosphorylation of CHK1 at dysfunctional telomeres when MRN function is abrogated. To test this hypothesis, we treated *Nbs1*^−/−^ MEFs bearing dysfunctional telomeres devoid of TRF2 and POT1a/b-TPP1 with the specific DNA-PK~cs~ inhibitor NU7441. The presence of 10 μM of NU7441 decreased both γ-H2AX and 53BP1 TIF formation by 3-fold and resulted in a 4-fold reduction in the number of chromosomal fusions repaired by A-NHEJ ([Figures 4A](#F4){ref-type="fig"}--[4D](#F4){ref-type="fig"}). These levels of TIF and fusion reductions are similar to those observed in cells expressing the Claspin^3A^ mutant. A 4-fold reduction in the level of CHK1 phosphorylation was also observed in *Nbs1*^−/−^ MEFs expressing TIN2^A110R^ or TPP1^ΔRD^ to generate dysfunctional telomeres lacking either TRF2-TIN2 or POT1a/b-TPP1 ([Figures 4E](#F4){ref-type="fig"} and [4F](#F4){ref-type="fig"}). These data support a critical role for DNA-PK~cs~ to promote efficient CHK1 phosphorylation in MRN-deficient cells bearing dysfunctional telomeres.

CPD Promote DNA End Resection at Telomeres Devoid of TRF2 and POT1a/b-TPP1 {#S7}
--------------------------------------------------------------------------

Telomeres lacking TRF2-POT1a/b-TPP1 recruit BARD1, CTIP, and BRCA1 in a CPD-dependent manner ([Figures 5A](#F5){ref-type="fig"} and [5B](#F5){ref-type="fig"}). The shRNA-mediated depletion of CPD decreased the telomeric localization of BARD1 and BRCA1 by \~3-fold ([Figures 5C](#F5){ref-type="fig"}, [5D](#F5){ref-type="fig"}, [S5A](#SD1){ref-type="supplementary-material"}, and [S5B](#SD1){ref-type="supplementary-material"}). These results suggest that BRCA1 and BARD1 play important roles in the repair of telomeres lacking TRF2-POT1a/b-TPP1 in the absence of functional MRN, a notion that is further supported by the observation that the depletion of BRCA1 in *NBS1-ILB1* cells devoid of TRF2-POT1-TPP1 reduced telomere fusions by 3-fold ([Figures 5E](#F5){ref-type="fig"}, [5F](#F5){ref-type="fig"}, and [S5C](#SD1){ref-type="supplementary-material"}). We also found that the shRNA-mediated depletion of exonucleases EXO1 and CTIP in *Nbs1*^−/−^ MEFs devoid of TRF2 and POT1a/b-TPP1 reduced end-to-end chromosome fusions by \~4-fold, suggesting that EXO1-mediated nucleolytic processing of the telomeric C-strand is required for A-NHEJ-mediated, MRN-independent repair of dysfunctional telomeres ([Figures 5E](#F5){ref-type="fig"}, [5F](#F5){ref-type="fig"}, and [S5D](#SD1){ref-type="supplementary-material"}). To test this notion, we performed telomere restriction fragment (TRF) southern to monitor the length of the G-overhang, which also provides an indication of the amount of C-strand processing. For example, increased C-strand processing would manifest as an increase in the amount of ss telomeric G-strand overhang observed ([@R32]; [@R46]). TRF southern of *Nbs1*^−/−^ MEFs devoid of TRF2 and POT1a/b-TPP1 and treated with 2 independent shRNAs targeting either EXO1, CTIP, or CPD individually revealed a reduction in the amount of G-overhang detected, suggesting a defect in C-strand processing ([Figures 5G](#F5){ref-type="fig"} and [5H](#F5){ref-type="fig"}). To rule out the possibility that this increase in G-overhang elongation is due to telomerase activity, we examined G-overhang formation in telomerase null generation 1 (G1) *mTR*^−/−^ MEFs after removing TRF2 and POT1a/b-TPP1. The lack of telomerase did not abolish the formation of γ-H2AX TIFs, A-NHEJ-mediated end-to-end chromosome fusion, or increased G-overhang formation on these dysfunctional telomeres, ruling out a role for telomerase in G-overhang elongation ([Figures S5E](#SD1){ref-type="supplementary-material"}--[S5J](#SD1){ref-type="supplementary-material"}). The depletion of *Exo1* in G1 *mTR*^−/−^ MEFs resulted in decreased G-overhang formation, further supporting the notion that increased nucleolytic C-strand processing by EXO1 mediates the length of the G-strand at telomeres lacking POT1a/b-TPP1 ([Figures S5I](#SD1){ref-type="supplementary-material"} and [S5J](#SD1){ref-type="supplementary-material"}). The shRNA-mediated depletion of CPD, EXO1, and CTIP also resulted in a corresponding decrease in CHK1 phosphorylation in *NBS-ILB1*, *Nbs1*^−/−^, and G1 *mTR*^−/−^ MEFs ([Figures 5I](#F5){ref-type="fig"}, [S5D](#SD1){ref-type="supplementary-material"}, and [S5K](#SD1){ref-type="supplementary-material"}). Finally, we addressed the possibility that compromised C-strand fill-in machinery resulted in increased G-overhang. The CTC1-STN1-TEN1 (CST) complex promotes C-strand fill-in with DNA Pol-α, and CST localization to telomeres requires POT1b ([Figures S5L](#SD1){ref-type="supplementary-material"} and [S5M](#SD1){ref-type="supplementary-material"}) ([@R32]; [@R92]). The expression of TPP1^ΔRD^ prevents STN1 localization to the 5′ telomeric ends by removing POT1b from telomeres ([Figure S5M](#SD1){ref-type="supplementary-material"}), compromising the C-strand fill-in machinery. However, even when C-strand fill-in synthesis is inhibited by TPP1^ΔRD^, the 3′ overhang is still elongated ([Figures 5G](#F5){ref-type="fig"}, [5H](#F5){ref-type="fig"}, [S5I](#SD1){ref-type="supplementary-material"}, and [S5J](#SD1){ref-type="supplementary-material"}). These results suggest that CPD, EXO1, and CTIP are required for the processing of the telomeric C-strand, generating the ss 3′ telomeric overhangs necessary for A-NHEJ-mediated repair.

TRF2 Interacts with Claspin to Recruit CPD and EXO1 to Dysfunctional Telomeres That Resemble Stalled Replication Forks {#S8}
----------------------------------------------------------------------------------------------------------------------

Telomeric DNA are difficult to replicate regions due to their repetitive nature and propensity to form G4 quadruplexes that can impede the progression of replicative DNA polymerases. POT1 represses the formation of these structures, and its depletion results in replication defects at telomeres ([@R61]; [@R70]; [@R101]). The localization of CPD to telomeres lacking POT1a/b-TPP1 suggests that these dysfunctional telomeres likely adopt difficult-to-repair secondary structures resembling stalled replication forks. Claspin has been shown to recognize and bind to branched/forked DNA structures containing both double-stranded and ssDNA to facilitate phosphorylation of CHK1 by ATR ([@R48]; [@R73]). We postulate that CPD is required to help resolve aberrant structures at ss telomeres lacking POT1-TPP1 to promote A-NHEJ repair. To test this hypothesis, we examined the localization of SMARCAL1 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A-like 1), an ATP-dependent annealing helicase that localizes to stalled replication forks to promote replication restart ([@R6]; [@R19]; [@R62]; [@R100]). In addition, SMARCAL1 localizes to telomeres undergoing replication stress ([@R19]). While cells lacking TRF2 displayed only background levels of SMARCAL1^+^ TIFs, 15% of U2OS cells lacking POT1-TPP1 displayed \>5 SMARCAL1^+^ TIFs ([Figures 6A](#F6){ref-type="fig"} and [S6A](#SD1){ref-type="supplementary-material"}). Removal of TRF2 and POT1-TPP1 from telomeres increased the number of cells bearing \>5 SMARCAL1^+^ TIFs to 25%. These results suggest that telomeres devoid of POT1-TPP1 adopt secondary structures that recruit CPD and SMARCAL1 to maintain telomere stability. In support of this observation, WT GFP-DONSON readily co-localized with HA-Claspin to telomeres lacking POT1-TPP1 and repressed the telomeric localization of SMARCAL1 to background levels ([Figures S6B](#SD1){ref-type="supplementary-material"}--[S6D](#SD1){ref-type="supplementary-material"}).

A recent report identified hypomorphic mutations in DONSON patients that increased the formation of stalled replication forks ([@R69]). DONSON mutants failed to co-localize with HA-Claspin to telomeres lacking POT1-TPP1 and are unable to suppress the telomeric localization of SMARCAL1 ([Figures S6B](#SD1){ref-type="supplementary-material"}--[S6D](#SD1){ref-type="supplementary-material"}). These results suggest that telomeres lacking POT1-TPP1 adopted aberrant secondary structures resembling stalled replication forks, leading to the recruitment of SMARCAL1 and CPD. Using immunofluorescence and fluorescence *in situ* hybridization (IF-FISH), we also found that endogenous EXO1 co-localized to dysfunctional telomeres with GFP-DONSON and HA-Claspin ([Figures 6B](#F6){ref-type="fig"} and [S6E](#SD1){ref-type="supplementary-material"}). Co-immunoprecipitation (Co-IP) experiments revealed that DONSON but not Claspin or PCNA interacts directly with EXO1 and CTIP ([Figures 6C](#F6){ref-type="fig"} and [S6F](#SD1){ref-type="supplementary-material"}). With the exception of DONSON^K489T^, all other DONSON mutants examined showed decreased interaction with EXO1 ([@R82]), CTIP, and Claspin ([Figures 6C](#F6){ref-type="fig"}, [S6G](#SD1){ref-type="supplementary-material"}, and [S6H](#SD1){ref-type="supplementary-material"}).

Following DNA replication, telomeres synthesized from the leading-strand template are blunt ended, while lagging-strand telomeres possess short ssDNA overhangs due to the removal of the terminal Okazaki fragment. Nucleolytic processing of the C-strand by MRE11 and Apollo/SNM1B, followed by more extensive processing by EXO1, generates the 3′ overhang at leading-strand telomeres inhibitory to both leading- and lagging-strand chromatid fusions ([@R46]; [@R92]). It is unclear how EXO1 is recruited to newly replicated telomeres. We postulate that the interaction of EXO1 with DONSON (and by extension, CPD) is required for its recruitment to newly replicated telomeres. In support of this notion, sequencing analysis revealed that the C terminus of Claspin possesses a highly evolutionarily conserved TRF2-binding motif (TBM), 1286Y/F/H-X-L-X-P~1290~ (where X is any amino acid), found only in proteins that interact with the TRF2 homology (TRFH) domain ([Figures 6D](#F6){ref-type="fig"} and [S6I](#SD1){ref-type="supplementary-material"}) ([@R13]). Isothermal titration calorimetry revealed that the Claspin^TBM^ peptide binds to TRF2^TRFH^ peptide with a K~d~ of 80 μM ([Figure 6E](#F6){ref-type="fig"}). To further validate TRF2 and Claspin interaction *in vivo*, we performed Co-IP experiments with endogenous proteins in both 293T and *Nbs1*^−/−^ MEFs. Co-IP results revealed that endogenous Claspin interacts with endogenous TRF2, and this interaction was completely abolished by the TRF2^F120A^ mutation, which has been shown to disrupt the ability of the TRF2^TRFH^ domain to interact with TBM-containing proteins ([Figures S7A](#SD1){ref-type="supplementary-material"}--[S7C](#SD1){ref-type="supplementary-material"}). These results suggest that the recruitment of Claspin to telomeres occurs via its specific interaction with TRF2.

To characterize the ability of CPD to recruit EXO1 to protect newly replicated telomeres, we used CO-FISH to interrogate *Apollo*/*SNM1B*^−/−^ MEFs ([@R46]; [@R91]). We found that CPD foci readily co-localized to *Apollo/SNM1B*^−/−^ telomeres ([Figure S7D](#SD1){ref-type="supplementary-material"}). Using CO-FISH to distinguish leading-strand (green signal) and lagging-strand (red signal) telomeres, we found that the deletion of Apollo/SNM1B results in an increase (\~5%) in the number of leading-leading-strand chromatid fusions characteristic of post-replicative repair, as well as increased G1/G2 and G2 chromosome fusions following progression through the cell cycle ([Figures 6F](#F6){ref-type="fig"}--[6H](#F6){ref-type="fig"} and [S7E](#SD1){ref-type="supplementary-material"}) ([@R46]; [@R91]). The shRNA-mediated depletion of CPD and EXO1 individually in *Apollo/SNM1B*^−/−^ MEFs resulted in a 2- to 3-fold increase in the number of both leading-strand and lagging-strand chromatid fusions and subsequent G1/G2 and G2 chromosome fusions, suggesting that CPD and EXO1 participate in the C-strand processing of both the leading-ends and the lagging-ends without the need for the enzymatic activity of Apollo/SNM1B to initiate nucleolytic cleavage ([Figures 6F](#F6){ref-type="fig"}--[6H](#F6){ref-type="fig"} and [S7F](#SD1){ref-type="supplementary-material"}). Expression of the DONSON mutants but not WT DONSON in *Apollo/SNM1B*^−/−^ MEFs increased the number of chromatid and chromosome aberrations, further supporting the notion that these cytogenetic aberrations arise due to defects in telomere replication ([Figures S7G](#SD1){ref-type="supplementary-material"} and [S7H](#SD1){ref-type="supplementary-material"}). We also detected a 10-fold increase in the number of chromosomes possessing interstitial telomeric signals (ITSs) of leading-strand and lagging-strand telomeres when CPD or EXO1 was individually depleted in *Apollo/SNM1B*^−/−^ MEFs ([Figures 6F](#F6){ref-type="fig"} and [S7I](#SD1){ref-type="supplementary-material"}). In addition, the hallmarks of DNA damage, including chromosome breaks, chromosome fragments, radial chromosomes, and fragile telomeres (indicative of telomere replication defects), were also observed when CPD or EXO1 was individually depleted ([Figures S7I](#SD1){ref-type="supplementary-material"} and [S7J](#SD1){ref-type="supplementary-material"}). These results suggest that TRF2-mediated recruitment of Apollo/SNM1B, CPD, DONSON, EXO1, and CTIP to newly replicated telomeres is required for nucleolytic processing of the C-strand at both leading and lagging chromosomes. EXO1 and CTIP generates the 3^′^ overhangs, enabling the loading of POT1-TPP1 to prevent the initiation of A-NHEJ-mediated chromosome and chromatid fusions. Depletion of CPD in an *Apollo/SNM1B*^−/−^ background further compromised G-overhang formation, resulting in the increased cytogenetic aberrations observed.

Mouse Tumors without Pot1a Experience Increased Replication Stress {#S9}
------------------------------------------------------------------

To determine whether the deletion of *Pot1a* promotes replication stress in solid tumors, we examined tumors derived from our *MMTV-Cre*^*+*^*; Pot1a*^*F/F*^*; p53*^*F/F*^ mouse tumor model ([@R31]). We found that 17/24 of mammary, sarcoma, and salivary tumors generated were genotyped as *Pot1a*^*F/Δ*^*; p53*^*Δ/Δ*^, while 7/24 were *Pot1a*^*Δ/Δ*^*; p53*^*Δ/Δ*^ ([Figures 7A](#F7){ref-type="fig"} and [S8A](#SD1){ref-type="supplementary-material"}; data not shown). Examination of 5 *MMTV-Cre*^*+*^*; Pot1a*^*Δ/Δ*^*; p53*^*Δ/Δ*^ tumors by western analysis revealed that they were segregated into 2 groups: a Claspin-low group (tumors 4 and 5) and a Claspin-high group (tumors 1--3) ([Figure 7A](#F7){ref-type="fig"}). In the Claspin-low group, p-RPA and p-CHK1 levels were almost undetectable, and γ-H2AX and p-RPA32^+^ TIFs were detected in only 20% of nuclei ([Figures 7A](#F7){ref-type="fig"}, [7D](#F7){ref-type="fig"}--[7F](#F7){ref-type="fig"}, [S8B](#SD1){ref-type="supplementary-material"}, and [S8C](#SD1){ref-type="supplementary-material"}). SMARCAL1^+^ TIFs were also low in these tumors ([Figures 7G](#F7){ref-type="fig"} and [S8D](#SD1){ref-type="supplementary-material"}), and end-to-end telomere fusions and interstitial telomeres involved only \~1.8% of all chromosome ends ([Figures 7H](#F7){ref-type="fig"} and [7I](#F7){ref-type="fig"}). In contrast, Claspin-high tumors expressed high levels of p-RPA32, p-CHK1, and SMARCAL1 by western analysis with increase Claspin and PCNA TIFs ([Figures 7A](#F7){ref-type="fig"}--[7C](#F7){ref-type="fig"}). We also detected \>5 γ-H2AX^+^ TIFs in 35% of cells and ≥3 p-RPA32^+^ TIFs in 12% of cells, along with increased co-localization of SMARCAL1 on telomeres ([Figures 7D](#F7){ref-type="fig"}--[7G](#F7){ref-type="fig"} and [S8B](#SD1){ref-type="supplementary-material"}--[S8D](#SD1){ref-type="supplementary-material"}). Amplification of ITS was found in \~12% of all chromosomes, with tumor number 3 showing such massive ITS amplifications that they can be detected in interphase nuclei ([Figures 7H](#F7){ref-type="fig"}, [7I](#F7){ref-type="fig"}, and [S8B](#SD1){ref-type="supplementary-material"}--[S8D](#SD1){ref-type="supplementary-material"}). Only a small region of the large ITSs contain DSBs that co-localize with γ-H2AX ([Figure S8B](#SD1){ref-type="supplementary-material"}). These results suggest that the deletion of *Pot1a* results in increased replication stress at telomeres in certain *Pot1a* null tumors, necessitating the increased expression of Claspin and SMARCAL1 to maintain telomere stability. In support of this observation, telomeric replication stress was not detected in *Pot1a*^*Δ/Δ*^*; p53*^*Δ*/*Δ*^ tumors, since γ-H2AX/p-RPA32^+^ TIFs, interstitial telomeres, and chromosomal aberrations were found at barely detectable levels ([Figures 7D](#F7){ref-type="fig"}--[7I](#F7){ref-type="fig"} and [S8B](#SD1){ref-type="supplementary-material"}--[S8C](#SD1){ref-type="supplementary-material"}). Correspondingly, Claspin and SMARCAL1 were undetectable by western analysis ([Figure 7A](#F7){ref-type="fig"}). To further examine the correlation of POT1 and Claspin levels in human cancer, we analyzed the status of Claspin and POT1 gene expression in 308 human colon carcinomas in The Cancer Genome Atlas (TCGA) database. We found a significant negative correlation between POT1 and Claspin gene expression in these cancers ([Figure 7J](#F7){ref-type="fig"}).

DISCUSSION {#S10}
==========

In this study, we describe unexpected roles for the replisome components Claspin, PCNA, and DONSON at telomeres. CPD is recruited to telomeres through the interaction of Claspin with TRF2-RAP1, while DONSON interacts with EXO1 and CTIP. Together, these proteins promote telomeric C-strand resection and the generation of 3′ G-overhangs, which serve as a platform for POT1-TPP1 binding to protect telomeres from initiating A-NHEJ repair ([Figure 7Ka](#F7){ref-type="fig"}). Dysfunctional telomeres lacking POT1-TPP1 also generate aberrant secondary structures that are inhibitory to A-NHEJ repair, requiring resolution by CPD and SMARCAL ([Figure 7Kb](#F7){ref-type="fig"}). In the absence of functional MRN, Claspin-mediated CHK1 phosphorylation and A-NHEJ repair requires DNA-PK~cs~ ([Figure 7Kc](#F7){ref-type="fig"}). Finally, mouse tumors lackingPot1a display increased telomere replication stress (RS) and elevated Claspin expression. Our results highlight the importance of CPD in promoting the A-NHEJ repair of dysfunctional telomeres lacking POT1-TPP1.

Role of Replisome Components in the Repair of Telomeres Lacking POT1-TPP1 by A-NHEJ {#S11}
-----------------------------------------------------------------------------------

Telomere DNA is difficult to replicate due to its highly repetitive nature and ability to form aberrant secondary structures that impede polymerase progression ([@R20]; [@R29]; [@R70]; [@R101]). TRF1 promotes normal fork progression through telomeres by recruiting the helicases RTEL1 and BLM to facilitate lagging-strand telomere synthesis by resolving G4 quadruplexes ([@R76]; [@R84], [@R85]). The interaction of RTEL1 with PCNA is essential for proper telomere replication. Our findings also highlight a role for the replisome in mediating the repair of dysfunctional telomeres. Telomeres devoid of POT1-TPP1 activate ATR-dependent hyper-resection of the 5′ C-strand, resulting in the generation of long 3′ ss overhangs ([@R42]). Since POT1-TPP1 functions to repress RPA from loading onto 3′ G-overhangs ([@R28]; [@R30]), we postulate that in the absence of POT1-TPP1, telomeres adopt aberrant secondary DNA structures similar to those found in stalled replication forks. Claspin specifically interacts with TRF2 to help resolve these structures and facilitate A-NHEJ repair independent of MRN status. In support of this notion, shRNA-mediated depletion of individual CPD components reduced A-NHEJ-mediated chromosome fusions to levels similar to those observed when Pol-q, PARP1, or ligase III are removed, indicative of their importance to promote the A-NHEJ repair of ss telomeric ends. Our data also suggest that CTIP, BRCA1, and EXO1 play roles in mediating the extensive 5′−3′ C-strand resection necessary to generate the long tracks of microhomologies necessary for A-NHEJ repair in the absence of TRF2-POT1-TPP1. Furthermore, localization of RPA to ssDNA represses Pol-q-mediated A-NHEJ repair and instead channels the ssDNA substrates for HR-mediated repair ([@R59]). Since telomeres lacking POT1-TPP1 cannot recruit RPA in the absence of MRN, they must be repaired through A-NHEJ.

While ITC revealed that the interaction between Claspin^TBM^ and TRF2^TRFH^ peptides is relatively weak, it is important to note that the ability of Claspin to localize to telomeres increases when both PCNA and DONSON are present ([Figures 2H](#F2){ref-type="fig"} and [S2I](#SD1){ref-type="supplementary-material"}), suggesting that the interaction of the CPD complex with TRF2 is likely substantially stronger than *in vitro* peptide interactions.

DNA-PK~cs~-Dependent, MRN-Independent Phosphorylation of CHK1 for A-NHEJ Repair {#S12}
-------------------------------------------------------------------------------

In the absence of the functional MRN complex, RPA localized poorly to damaged ssDNA, preventing the activation of ATR-ATRIP and downstream damage signaling through CHK1 ([@R39]; [@R57]; [@R79]; [@R99]). However, NBS1 has been shown to directly activate ATR independently of MRE11 and TOPBP1 function ([@R43]). The *Ustilago maydis* Claspin homolog Mrc1 but not MRN is required to initiate the CHK1-dependent DNA damage response necessary for cell-cycle arrest ([@R81]). This result suggests that MRN activation of the ATR/CHK1 pathway is dispensable under certain DNA damage conditions, and that Claspin could substitute for MRN function. In the absence of functional MRN, RPA and ATRIP fail to localize to telomeres lacking POT1-TPP1, suggesting that the MRN-ATRIP-ATR cascade required for CHK1 phosphorylation is dispensable for A-NHEJ repair. We now show that DNA-PK~cs~ can substitute for MRN function by promoting CHK1 phosphorylation and A-NHEJ-mediated repair at telomeres lacking POT1-TPP1, an observation that is in line with a previous report suggesting that DNA-PK~cs~ is required to maintain Claspin-CHK1 complex stability ([@R53]).

CTIP Functions Independently of MRN for A-NHEJ Repair of Dysfunctional Telomeres Lacking POT1a/b-TPP1 {#S13}
-----------------------------------------------------------------------------------------------------

In mammalian cells, MRE11-CTIP nucleases are required to resect DSBs to generate the resected 3′ overhangs necessary for annealing and A-NHEJ repair ([@R10]; [@R25]; [@R68]; [@R93]). While MRN-CTIP is essential for C-NHEJ-mediated repair of telomeres lacking TRF2 ([@R2]; [@R23]; [@R25]), our data indicate that MRN but not CTIP is dispensable for A-NHEJ-mediated repair of telomeres lacking POT1a/b-TPP1. While CTIP has been shown to enhance the nuclease activity of MRE11 to promote A-NHEJ repair ([@R4]; [@R7]; [@R42]; [@R49]; [@R68]; [@R74]; [@R93]; [@R102]), CTIP nuclease activity independent of MRN function has also been reported ([@R49]). Our data strongly suggest that at least at telomeres lacking POT1a/b-TPP1, CTIP is required to promote A-NHEJ mediated repair in the absence of the functional MRN complex, a notion that is consistent with the MRN-independent nuclease activity of CTIP/Sae2 ([@R51]; [@R56]; [@R63]; [@R89]; [@R98]).

POT1 Protects Tumors from Replication Stress {#S14}
--------------------------------------------

At stalled replication forks, RPA serves as a platform to recruit fork repair proteins to promote fork restart and restore replication ([@R8]). After fork restart, RPA must be displaced for DNA replication to proceed normally. POT1 has been shown to participate in RPA exclusion at telomeres ([@R28]). We postulate that POT1 may serve an analogous function at telomere replication forks. The deletion of POT1 is thus expected to result in increased replicative stress at telomeres. A subset of *MMTV-Cre; Pot1a*^*Δ/Δ*^*; p53*^*Δ/Δ*^ tumors show high levels of Claspin expression, elevated p-CHK1 levels, and increased localization of γ-H2AX and SMARCAL1 to telomeres, all indicative of increased telomere replication stress. Our data suggest that the upregulation of Claspin is required to maintain genome stability in tumors with high levels of RS. In support of this notion, a recent report demonstrates that the increased expression of Claspin, Timeless, and CHK1 is observed in a diverse array of primary human tumors to enable tolerance to increased RS and maintain the integrity of the replication fork ([@R9]).

STAR★METHODS {#S15}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S16}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Dr. Sandy Chang (<s.chang@yale.edu>). All plasmids and cell lines generated in this study are available on request without restrictions.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S17}
--------------------------------------

### Cell lines {#S18}

Human *NBS-ILB1* cells, *Nbs1*^*+/+*^*, Nbs1*^−/−^, *G1 mTR*^−/−^ and *Apollo/SNM1B*^−/−^ MEFs and 293T were cultured in DMEM supplemented with 10% FBS and maintained in 5% CO2 at 37° C. U2OS cells were cultured in Macoy's medium. Source of U2OS, 293T and MEFs used in this study are listed in the [Key Resources Table](#T1){ref-type="table"}.

### Mouse tumor model for generation of MMTV-Cre; mPot1a^F/F^; p53^F/F^ tumor cell lines {#S19}

To generate *MMTV-Cre; mPot1a*^*F/F*^*; p53*^*F/F*^ mice, *MMTV-Cre* mice (The Jackson Laboratory, Tg (MMTV-cre) 4Mam/J; stock number: 003553) were first crossed with *mPot1a*^*F/F*^ mice ([@R90]) to generate *MMTV-Cre; mPot1a*^*F/F*^ mice. *MMTV-Cre; mPot1a*^*F/F*^ mice were then crossed with *p53*^*F/F*^ (The Jackson Laboratory, B6.129P2-Trp53tm1Brn/J; Stock No:008462) mice to generate *MMTV-Cre; mPot1a*^*F/F*^*; p53*^*F/+*^ and *MMTV-Cre; mPot1a*^*F/F*^*; p53*^*F/F*^ mice. *mPot1a*^*F/F*^ and *mPot1a*^*F/F*^*; p53*^*F/F*^ mice were generated as controls. All mice were maintained under basic care conditions according to the IACUC-approved protocols of Yale University. Sick mice (age 7--12 months old; [Table S1](#SD1){ref-type="supplementary-material"}) were sacrificed and tumors were harvested from breast glands or other organs. Chopped tumors were digested with 0.25% trypsin at 37° C for 15min followed by collagenase D treatment at 37° C for 30 min. The digested suspension was filtered through 40μm cell strainer and isolated tumor cells were pelleted by centrifugation and expanded by passaging in the DMEM with 10% FBS culture media.

METHOD DETAILS {#S20}
--------------

### Retroviral infection {#S21}

DNA constructs were transfected into 293T cells using Fugene 6 and packaged into retro or lentiviral particles. Viral supernatant was collected 48--72 h after transfection, filtered and directly used to infect immortalized MEFs or human cells.

### Western blot analysis {#S22}

For immunoblotting, trypsinized cells were lysed in urea lysis buffer (8 M urea, 50 mM Tris-HCl, pH 7.4, and 150 mM β-mercaptoethanol). The lysates were denatured and then resolved on SDS--PAGE gel. The separated proteins were then blotted on a nitrocellulose plus membrane (Amersham), blocked with blocking solution (5% non-fat dry milk in PBS/0.1% Tween-20) for at least 1 h and incubated with appropriate primary antibody in blocking solution at least 2 h at room temperature or overnight at 4 °C. The membranes were washed 3 × 5 min with PBS/0.1% Tween-20 and incubated with appropriate secondary antibody in blocking solution for 1 h at room temperature. Chemiluminescence detection was performed using an ECL Western Blotting Detection kit from GE Healthcare.

### Immunofluorescence and fluorescent in situ hybridization {#S23}

Cells grown on coverslips were fixed for 10 min in 2% (w/v) sucrose and 2% (v/v) paraformaldehyde at room temperature followed by PBS washes. Coverslips were blocked in 0.2% (w/v) fish gelatin and 0.5% (w/v) BSA in PBS. Cells were incubated with primary antibodies and after PBS washes, cells were incubated with appropriate Alexa fluor secondary antibodies followed by washes in PBS + 0.1% Triton. IF-FISH was carried out using a TelC-Cy3 PNA telomere probe (PNA Bio). DNA was stained with DAPI, and digital images captured using NIS-Elements BR (Nikon) with a Nikon Eclipse 80i microscope and an Andor CCD camera.

### Coimmunoprecipitation {#S24}

293T cells grown in 10 cm plates were co-transfected with epitope tag cDNAs or vector control. 48 h after transfection, cells were harvested and lysed in buffer (20 mM HEPES, pH 7.5, 10% glycerol, 1mM EDTA, 0.5% (v/v) NP-40). Supernatants were immunopre-cipitated with appropriate endogenous or protein tagged antibody conjugated agarose beads (Sigma). Beads were washed thrice and eluted proteins analyzed by SDS-PAGE.

### Isothermal titration calorimetry {#S25}

The equilibrium dissociation constants between the WT and mutant TRF2^TRFH^ and Claspin^TBM^ peptides were determined using an iTC~200~ calorimeter (MicroCal). The enthalpies of binding between the TRF2^TRFH^ domain and the Claspin^TBM^ were measured at 20° C in 25 mM Tris-HCl (pH8.0) and 150 mM NaCl. ITC data were subsequently analyzed and fitted using Origin 7 software (OriginLab) with blank injections of peptides into buffer subtracted from the experimental titrations prior to data analysis.

### DNA binding assay {#S26}

To examine whether CPD complex bind to ss telomeric DNA *in vitro*, 293T cells expressing GFP DONSON or HA-Claspin lysed in TEB~150~ buffer (50 mM HEPES pH 7.3, 150 mM NaCl, 2 mM MgCl~2~, 5 mM EGTA, 0.5% Triton X-100, 10% Glycerol, proteinase inhibitors) were incubated with streptavidin--agarose beads (Thermo-Fisher) coated with biotin-Tel-G (TTAGGG)~6~ or TEL-C (CCCTAA)~6~ or Oligo (dT)~6~ DNA oligos overnight at 4 ° C. POT1a^WT^ and POT1a^F62^ protein lysates used as positive control ([@R90]). Bound complexes were washed three times with the same buffer and eluted proteins analyzed by SDS-PAGE.

### Cell Cycle analysis {#S27}

For FACS analysis, cells washed in PBS fixed with 70% ice-cold ethanol by drop-wise mixing, and incubated for at least 24 h in-20° C. Cells washed twice with PBS and then resuspended in 0.5 mL PBS containing 50 μg/ml of propidium iodide and 100 μg/ml of RNase A. The samples were analyzed on a BD LSR Fortessa cytometer. Data analysis was performed using FlowJo software. Cell cycle dependent expression of Claspin in U2OS cells was determined using Fucci system based on fluorescent proteins with fragments of CDT1 and Geminin, for the G1 and S/G2 reporters, respectively ([@R72]).

### Chromosome analysis by telomere PNA-FISH and CO-FISH {#S28}

Cells were treated with 0.5 μg/ml of Colcemid before harvest. Chromosomes were fixed and telomere PNA-FISH performed with aTelC-Cy3 probe (PNA Bio) as described ([@R66]; [@R90]). For CO-FISH, metaphase spreads were incubated sequentially with TelG-FAM and TelC-Cy3 probes. Images were captured as described above. The percent of chromosome fusions observed is defined as: total number of chromosome fusions in 30--50 metaphase spreads analyzed divided by the total number of chromosomes examined X 100%.

### Telomere length analysis and G-Strand overhang assays {#S29}

For in-gel detection of telomere length and G-stand overhang, a total of 1--2 × 10^6^ cells were suspended in PBS, mixed 1:1 with 1.8% agarose in 1 × PBS and cast into plugs. The plugs were then digested overnight at 50 ° C with 20 mg ml^−1^ Proteinase K (Roche) in 10 mM sodium phosphate (pH 7.2) and 0.5 mM EDTA and 1% sodium lauryl sarcosine. DNA in plugs were subsequently digested by *Hin*f1/*Rsa*1 overnight at 37 ° C. The next morning, plugs were washed once with 1 × TE and equilibrated with 0.5 × TBE. The plugs were loaded onto a 0.8% agarose gel in 0.5 ×TBE and run on a CHEF-DRII pulse field electrophoresis apparatus (Bio-Rad). The electrophoresis parameters were as follows: Initial pulse: 0.3 s, final pulse: 16 s, voltage: 6 V cm^−1^, run time: 14 h. Dried gel pre-hybridized with Church mix for 2 h at 55 ° C and hybridized overnight at 55 ° C in Church mix with ^32^P-labeled T~2~AG~3~ oligonucleotides. After hybridization, the gel was washed three times for 30 min with 4 × SSC/0.1% SDS at 37 ° C, thrice with 4 ×SSC/0.1% SDS at 55 °C and exposed to a phosphoimager screen overnight. After exposure, the screen was scanned on a Typhoon Trio imager system and the gel was subsequently denatured and hybridized using the same probe.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S30}
---------------------------------------

Statistics for TIFs and chromosome fusions were determined in term of p value from one-way Anova using GraphPad Prism software (Version 7.0).

DATA AND CODE AVAILABILITY {#S31}
--------------------------

This study did not generate/analyze datasets/code.
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![Telomeres Devoid of TRF2 and POT1-TPP1 Are Repaired in an MRN-Independent Manner\
(A) *Nbs1*^*+/+*^ *and Nbs1*^−/−^ MEFs expressing the indicated DNA constructs for 120 h and TelG-FAM (green, leading-strand), TelC-Cy3 (red, lagging-strand), and DAPI (blue) were used to visualize fused chromosomes (arrowheads). Scale bar for all panels: 5 μm.\
(B) Telomere fusion frequencies in *NBS-ILB1* cells and in (A). Data are the average of 2 independent experiments ± SD from a minimum of 80 metaphases. \*\*\*p = 0.0002, \*\*\*\*p \< 0.0001 by 1-way ANOVA. ns, non-significant.\
(C) Immunoblot to detect total (T)-CHK1, T-CHK2, phosphorylated (p)-CHK1, and p-CHK2 in *Nbs1*^*+/+*^ *and Nbs1*^−/−^ cells expressing indicated proteins. γ-Tubulin, loading control. NS, nonspecific band.\
(D) *Nbs1*^−/−^ MEFs and *NBS-ILB1* cells expressed the indicated DNA constructs for 120 h. TelG-FAM (green), TelC-Cy3 (red), and DAPI (blue) were used to visualize fused chromosomes (arrowheads). Scale bar for all panels: 5 μm.\
(E) Telomere fusion frequencies in (D). Data are the average of 3 independent experiments ± SD from a minimum of 120 metaphases. \*\*p = 0.002, \*\*\*p = 0.0002, \*\*\*\*p \< 0.0001 by 1-way ANOVA. Ns, non-significant.](nihms-1546251-f0002){#F1}

![Recruitment of CPD to Telomeres Lacking TRF2 and POT1a/b-TPP1\
(A) Co-localization of p-RPA32, RAD51, and Flag-ATRIP with telomeres (arrowheads) in *Nbs1*^*+/+*^, *Nbs1*^−/−^ MEFs, or *NBS-ILB1* cells. Telomeres were visualized by peptide nucleic acid-fluorescent *in situ* hybridization (PNA-FISH) (red), indicated proteins (green), and nuclei (blue). Scale bar for all panels: 5 μm.\
(B) Percentage of cells containing ≥5 TIFs in (A). Data are the mean of 2 independent experiments ± SD; n \> 200 nuclei analyzed per experiment. \*\*\*\*p \< 0.0001 by 1-way ANOVA. ns, non-significant.\
(C) Co-IP of HA-Claspin with GFP-DONSON or Myc-PCNA in 293T cells. Input, 5% of the total cell lysate. γ-Tubulin, loading control.\
(D--F) Localization of Claspin (D), PCNA (E), and DONSON (F) in *Nbs1*^−/−^ MEFs expressing indicated DNAs. Endogenous DONSON TIFs were detectable only in HA-claspin-expressing cells. Telomeres were visualized by PNA-FISH (red), and endogenous CPD was visualized with the indicated antibodies (green). Scale bar for all panels: 5 μm.\
(G) Percentage of cells containing ≥5 CPD^+^ foci co-localizing with telomeres, detected in (D)--(F).\
(H) Co-expression of HA-Claspin with GFP-DONSON (top panel) or HA-Claspin, Myc-PCNA, and GFP-DONSON (bottom panel) in U2OS cells. Top panel: GFP-DONSON (green) and HA-Claspin(red). Bottom panel: Myc-PCNA (red) and GFP-DONSON (green). For bothpanels, anti-TRF2 antibody visualized telomeres (white).\
(I) HA-Claspin and GFP-DONSON co-localized with BrdU^+^ foci in U2OS cells. GFP-DONSON (green), BrdU (red), and DAPI (blue). Scale bar for all panels: 5 μm.](nihms-1546251-f0003){#F2}

![CPD Promotes A-NHEJ-Mediated Chromosome Fusions in the Absence of NBS1\
(A) Percentage of cells containing ≥5 γ-H2AX^+^ TIFs in *Nbs1*^*+/+*^ *and Nbs1*^−/−^ MEFs expressing the indicated DNAs. Data are the mean of 3 independent experiments ± SD; n \> 300 nuclei analyzed per experiment. \*\*\*p = 0.0002, \*\*\*\*p \< 0.0001 by 1-way ANOVA.\
(B) Telomere fusion frequencies in *Nbs1*^*+/+*^ cells treated with sh*Trf2*, TPP1^ΔRD^, or both. Data are the average of 3 independent experiments ± SD from a minimum of 140 metaphases. \*p = 0.01, \*\*p = 0.001, \*\*\*\*p \< 0.0001 by 1-way ANOVA. ns, non-significant.\
(C) Telomere fusion frequencies in *Nbs1*^−/−^ treated with sh*Trf2*, TPP1^ΔRD^, or both. Data are the average of 3 independent experiments ± SD from a minimum of 140 metaphases. \*\*p = 0.001, \*\*\*p = 0.0001, \*\*\*\*p \< 0.0001 by 1-way ANOVA. ns, non-significant.\
(D) Domain organization of Claspin. Replication fork-interacting domain, basic patch I, basic patch II, PCNA-interacting domain, CHK1-binding domain, and C-terminal acidic patch. The red dashed line separates Claspin^N-Ter^ (amino acids \[aa\] 1--679) and Claspin^C-Ter^ (aa 679--1,332).\
(E) *Nbs1*^−/−^ MEFs expressed the indicated DNA constructs for 120 h. TelG-FAM, TelC-Cy3, and DAPI-labeled metaphase spreads to visualize fused chromosomes (arrowheads). Scale bar for all panels: 5 μm.\
(F) Percentage of cells containing ≥5 γ-H2AX TIFs observed in (E). Data are the mean of 2 independent experiments ± SD; n \> 200 nuclei analyzed per experiment. \*\*p = 0.01, \*\*\*p = 0.001, by 1-way ANOVA. ns, non-significant.\
(G) Telomere fusion frequencies in (E). Data are the average of 2 independent experiments ± SD from a minimum of 70 metaphases. \*\*p = 0.001, \*\*\*p = 0.0001, \*\*\*\*p \< 0.0001 by 1-way ANOVA. ns, non-significant.\
(H) Co-IP of HA-Claspin^WT^, HA-Claspin^N-Ter^, or HA-Claspin^C-Ter^ with GFP-DONSON in 293T cells. Input, 5% of the total cell lysate. γ-Tubulin, loading control.\
(I) U2OS cells transiently transfected with HA-Claspin^WT^, HA-Claspin^3A^, HA-Claspin^N-Ter^, or HA-Claspin^C-Ter^ with GFP-DONSON for 48 h. GFP-DONSON (green), HA-Claspin (red), and DAPI to visualize nuclei (blue). Scale bar for all panels: 5 μm.\
(J) Percentage of cells containing ≥5 γ-H2AX^+^ TIFs in *Nbs1*^−/−^ MEFs infected with indicated DNA constructs. Data are the mean of 2 independent experiments ± SD; n \> 200 nuclei analyzed per experiment. \*\*p = 0.001, \*\*\*p = 0.0003 by 1-way ANOVA. ns, non-significant.\
(K) Telomere fusion frequencies. Data are the average of 3 independent experiments ± SD from a minimum of 120 metaphases. \*\*\*p = 0.001, \*\*\*\*p \< 0.0001 by 1-way ANOVA. ns, non-significant.](nihms-1546251-f0004){#F3}

![Inhibition of DNA-PK~cs~ Abolishes DDR and A-NHEJ-Mediated Chromosome Fusions in *Nbs1*^−/−^ Cells\
(A) *Nbs1*^−/−^ cells expressing the indicated DNA constructs were treated with DMSO or 10 μM DNA-PK~cs~ inhibitor NU7441 and γ-H2AX, and 53BP1^+^ TIFs were detected. Telomeres were visualized by PNA-FISH (red), proteins (green), and nuclei (blue). Scale bar for all panels: 5 μm.\
(B) Percentage of cells containing positive γ-H2AX and 53BP1 TIFs in (A). Data are the mean of 2 independent experiments ± SD; n \> 200 nuclei analyzed per experiment. \*\*\*p = 0.0002, \*\*\*\*p \< 0.0001 by 1-way ANOVA.\
(C) *Nbs1*^−/−^ MEFs expressing indicated DNA constructs were treated with DMSO or 10 μM NU7441 for 120 h. TelG-FAM, TelC-Cy3, and DAPI were used to visualize fused chromosomes (arrowheads).\
(D) Telomere fusion frequencies in (C). Data are the average of 2 independent experiments ± SD from a minimum of 80 metaphases. \*\*p = 0.001, \*\*\*p =0.0005 by 1-way ANOVA. Scale bar for all panels: 5 μm.\
(E and F) Immunoblot for p-CHK1 levels in *Nbs1*^−/−^ cells expressing either TIN2^A110R^ (E) or TPP1^ΔRD^ (F) treated with DMSO or NU7441. γ-tubulin, loading control. NS, nonspecific band.](nihms-1546251-f0005){#F4}

![CPD Complex Promotes DNA End Resection at Telomeres Devoid of TRF2 and POT1-TPP1\
(A) BARD1, CTIP, and BRCA1 co-localized with telomeres (arrowheads) in *Nbs1*^−/−^ MEFs and *NBS1-ILB1* cells treated with sh*Trf2* and TPP1^ΔRD^. Telomeres were visualized by PNA-FISH (red), proteins (green), and nuclei (blue). Scale bar for all panels: 5 μm.\
(B) Percentage of cells containing ≥5 TIFs in (A). Data represent the mean of 3 independent experiments ± SD; n \> 250 nuclei analyzed per experiment. \*\*\*p = 0.0001, \*\*\*\*p \< 0.0001 by 1-way ANOVA.\
(C) Percentage of cells with ≥5 BARD1^+^ TIFs in *Nbs1*^*+/+*^ or *Nbs1*^−/−^ MEFs treated with the indicated shRNAs and sh*Trf2* + TPP1^ΔRD^. Data represent the average of 3 independent experiments ± SD; n \> 250 nuclei analyzed per experiment. \*p = 0.02, \*\*\*\*p \< 0.0001 by 1-way ANOVA.\
(D) Percentage of cells with ≥5 BRCA1^+^ TIFs in *NBS1-ILB1* cells treated with sh*Claspin 1* or *2* and TRF2^ΔBΔM^ + TPP1^ΔRD^. Data represent the average of 2 independent experiments ± SD from a minimum of 200 nuclei analyzed per experiment. \*\*p = 0.002, \*\*\*p = 0.0008 by 1-way ANOVA. ns, non-significant.\
(E) *Nbs1*^−/−^ or *NBS1-ILB1* cells were treated with the indicated DNA constructs for 120 h. TelG-FAM, TelC-Cy3, and DAPI were used to visualize fused chromosomes (arrowheads). Scale bar for all panels: 5 μm.\
(F) Telomere fusion frequencies in (E). Data represent the average of 2 independent experiments ± SD from a minimum of 90 metaphases. \*\*\*p = 0.0002, \*\*\*\*p \< 0.0001 by 1-way ANOVA. ns, non-significant.\
(G) Effect of indicated shRNAs on telomere end resection in *Nbs1*^−/−^ MEFs using in-gel hybridization with radiolabeled (CCCTAA)~4~ probes to detect 3′ ss overhang under native conditions (left) and denaturing conditions to detect total TTAGGG repeats (right).\
(H) Quantification of telomeric overhang signals in (G). Single-stranded TTAGGG signals were normalized to the total TTAGGG signal in the same lane and set to 100, and all of the other values are displayed relative to this value.\
(I) Immunoblots were examined for the level of indicated proteins in *Nbs1*^−/−^ MEFs expressing indicated DNA constructs and shRNAs targeting CPD. γ-tubulin, loading control. NS, nonspecific band.](nihms-1546251-f0006){#F5}

![CPD and EXO1 Are Recruited by TRF2 to Dysfunctional Telomeres That Resemble Stalled Replication Forks\
(A) SMARCAL1 co-localizes with telomeres in U2OS cells expressing the indicated cDNAs. Telomere PNA-FISH (red), antibody staining (green), and DAPI (blue). Scale bar for all panels: 5 μm.\
(B) Co-localization of GFP-DONSON and HA-Claspin with endogenous EXO1 at telomeres. Data represent the mean of 2 independent experiments ± SD; n \> 150 nuclei analyzed per experiment. \*p = 0.01, \*\*p = 0.001 by 1-way ANOVA. ns, non-significant.\
(C) WT GFP-DONSON or mutant DONSON interactions with V5-EXO1. Inputs represent 5% of the total cell lysate used for the IP. γ-tubulin, loading control.\
(D) (Top) diagram illustrating that the TRF2^TRFH^ domain interacts with the Claspin^TBM^ domain in its C terminus. (Bottom) representative proteins that contain the TBM (F/Y/H-X-L-X-P) are indicated.\
(E) ITC measurements of the interaction between TRF2^TRFH^ and Claspin^TBM^ peptides.\
(F) Chromosome and chromatid fusions in *Apollo/SNM1B*^−/−^ MEFs treated with indicated shRNAs for 120 h. TelG-FAM, TelC-Cy3, and DAPI were used to visualize fused chromosomes (arrowheads). Representative G1/G2 chromosome fusions (white arrows), G2 chromosome fusions (orange arrows), leading-leading strand (green arrows), sister-sister telomere fusion (pink arrows), and interstitial telomeres (red arrows) are indicated. Scale bar for all panels: 5 μm.\
(G) Quantification of G1/G2 and G2 chromosome-type fusions in (F). Data represent the mean of 2 independent experiments ± SD from a minimum of 50 metaphases analyzed per experiment.\
(H) Quantification of the chromatid-type and sister fusions in (F). Data represent the mean of 2 independent experiments ± SD from a minimum of 50 metaphases analyzed per experiment.](nihms-1546251-f0007){#F6}

![Genomic Instability in Tumors Derived from MMTV-Cre; p53^*F/F*^; Pot1a^*F/F*^ Mice\
(A) CPD, SMARCAL1, p-CHK1, and p-RPA32 expression in MMTV-Cre; *p53*^*Δ/Δ*^; *Pot1a*^*Δ/Δ*^ breast tumors (\#1, 3, and 4), sarcoma (\#2), and salivary gland tumor (\#5). Tumor \#6 is MMTV-Cre; *p53*^*Δ/Δ*^; *Pot1a*^*F/ΔΔ*^. γ-Tubulin, loading control. Bottom panel: PCR genotyping.\
(B) Detection of Claspin and PCNA (green) and telomeres (red) in tumor \#1.\
(C) Percentage of cells containing ≥3 Claspin/PCNA (CP^+^) TIFs in (B). Scale bar for all panels: 5 μm.\
(D) γ-H2AX TIFs in tumor cell lines. Telomere PNA-FISH (red), antibody staining (green), and nuclei (blue). Scale bar for all panels: 5 μm.\
(E) Percentage of cells containing ≥5 γ-H2AX TIFs in (D). Data represent the mean of 2 independent experiments ± SD; n \> 200 nuclei analyzed per experiment. \*p = 0.01, \*\*p = 0.001, \*\*\*p = 0.0001 by 1-way ANOVA.\
(F) Percentage of cells containing ≥3 p-RPA32 TIFs in tumor cell lines.\
(G) SMARCAL1 TIFs in tumor cell lines.\
(H) Interstitial telomeres (red arrow), chromosome and sister chromatid fusions (orange arrow) in *Pot1a* deleted mouse tumor cell lines. TelG-FAM, TelC-Cy3, and DAPI were used to visualize fused chromosomes. Scale bar for all panels: 5 μm.\
(I) Quantification of the number of interstitial telomeres and chromosome fusions in (H). Data represent the average of 2 independent experiments ± SD from a minimum of 70 metaphases.\
(J) Spearman's correlation between claspin and POT1 gene expression in colon adenocarcinoma obtained from TCGA data.\
(K) Schematic depicting CPD functions. See text for details.](nihms-1546251-f0008){#F7}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                               SOURCE                                      IDENTIFIER
  ----------------------------------------------------------------- ------------------------------------------- ------------------------------
  Antibodies                                                                                                    
  Rabbit anti phospho-CHKI                                          Cell Signaling Technology                   2348; RRID: AB_331212
  Mouse anti phospho-CHK2                                           BD Biosciences                              611570; RRID: AB_399016
  Mouse anti γ-H2AX                                                 Millipore                                   05--636; RRID: AB_309864
  Mouse anti-TRF2                                                   Millipore                                   05--521; RRID: AB_2303145
  Mouse anti-Myc                                                    Millipore                                   05--724, RRID: AB_309938
  Rabbit anti-RAD51                                                 Santacruz                                   sc-8349, RRID: AB_2253533
  Mouse anti-BRCA1                                                  Santacruz                                   sc-6954, RRID: AB_626761
  Rabbit anti-BARD1                                                 Santacruz                                   sc-11438; RRID: AB_2061240
  Rabbit anti-CTIP                                                  Santacruz                                   sc-22838, RRID: AB_2175257
  Mouse anti-SMARCAL1                                               Santacruz                                   sc-376377, RRID: AB_10987841
  Rabbit anti-PCNA                                                  Santacruz                                   sc-7907, RRID: AB_2160375
  Mouse anti-GFP                                                    Santacruz                                   sc-9996; RRID: AB_627695
  Rabbit anti-53BP1                                                 Santacruz                                   sc-22760; RRID: AB_2256326
  Rabbit anti-EXO1                                                  Santacruz                                   sc-33194, RRID: AB_2101433
  Mouse RAD52                                                       Santacruz                                   sc-365341, RRID: AB_10851346
  Mouse anti-Flag                                                   Sigma-Aldrich                               F3165; RRID: AB_259529
  Mouse anti-HA                                                     Sigma-Aldrich                               H3663; RRID: AB_262051
  Rabbit anti-V5                                                    Sigma-Aldrich                               V8137, RRID: AB_261889
  Mouse anti-γ-Tubulin (clone GTU-488)                              Sigma-Aldrich                               T6557; RRID: AB_477584
  Mouse anti-Myc agarose beads                                      Sigma-Aldrich                               A7470; RRID: AB_10109522
  Mouse anti-Flag M2 affinity Gel                                   Sigma-Aldrich                               A2220; RRID: AB_10063035
  Mouse anti-HA agarose beads                                       Sigma-Aldrich                               A2095, RRID: AB_257974
  Rabbit anti-DONSON                                                Sigma-Aldrich                               AV45862, RRID: AB_1847828
  Rabbit anti-DONSON                                                Invitrogen                                  PA5--61865, RRID: AB_2640751
  Rabbit anti-Claspin                                               Abcam                                       ab3720, RRID: AB_2245123
  Rabbit anti-Claspin                                               Novus                                       NB100--248, RRID: AB_2082897
  Rabbit anti-Claspin                                               Bethyl Laboratories                         A300--266A, RRID: AB_155895
  Rabbit anti phospho-RPA32 (S4/S8)                                 Bethyl Laboratories                         A300--245A, RRID: AB_210547
  Mouse anti PCNA                                                   Bio-Rad                                     VMA00018
  Rabbit anti-mTRF2                                                 Karlsedar Lab                               N/A
  Streptavidin-Agarose resin                                        Thermo Scientific                           20359
  Bacterial and Virus Strains                                                                                   
  XL1-Blue Supercompetent cells                                     Agilent Technologies                        200518
  XL10-Gold Ultracompetent Cells                                    Agilent Technologies                        200315
  Chemicals, Peptides, and Recombinant Proteins                                                                 
  DNA-PKcs inhibitor NU7441                                         Selleckchem                                 S2638
  Critical Commercial Assays                                                                                    
  Site-directed mutagenesis                                         Stratagene                                  200521
  TRAPeze Telomerase Detection Kit                                  Fisher Scientific                           S7700
  Experimental Models: Cell Lines                                                                               
  Human *NBS-ILB1* cells                                            [@R27], EMBO Reports.                       N/A
  U2OS                                                              ATCC                                        N/A
  293T                                                              ATCC                                        CRL-3216, RRID: CVCL_0063
  *Nbs1*^−/−^ MEFs                                                  [@R60], Adv Biophys.                        N/A
  *Apollo/SNM1B*^−/−^ MEFs                                          [@R46], EMBO J.                             N/A
  *G1 mTR*^−/−^ MEFs                                                This paper                                  N/A
  *MMTV-Cre*^*+*^*; Pot1a*^*F/Δ*^*; p53*^*Δ/Δ*^ MEFs                [@R31]                                      N/A
  *MMTV-Cre*^*+*^*; Pot1a*^*Δ/Δ*^*; p53*^*Δ/Δ*^ MEFs                                                            
  Experimental Models: Organisms/Strains                                                                        
  *MMTV-Cre*^*+*^*; Pot1a*^*F/F*^*; p53*^*F/F*^ mouse tumor model   [@R31]                                      N/A
  Oligonucleotides                                                                                              
  Biotin-Tel-G (IIAGGG)~6~                                          This paper                                  N/A
  Biotin-Tel-C (CCCTAA)~6~                                          This paper                                  N/A
  Biotin Oligo (dT)~6~                                              This paper                                  N/A
  TelC-Cy3 (CCCTAA)~3~                                              PNABio                                      F1002
  TelG-FAM (TTAGGG)~3~                                              PNABio                                      F1005
  Recombinant DNA                                                                                               
  pBabe puro Myc-hTRF2^ΔBΔM^                                        [@R67], Molecular Cell                      N/A
  pQCXIP puro Flag-hTPP1^ΔRD^                                       [@R67], Molecular Cell                      N/A
  pQCXIP puro HA-hTPP1^ΔRD^                                         [@R67], Molecular Cell                      N/A
  pQCXIP puro HA-mTPP1^ΔRD^                                         [@R67], Molecular Cell                      N/A
  pQCXIP puro Flag-mTPP1^ΔRD^                                       [@R67], Molecular Cell                      NA
  pQCXIP puro Flag-mNBS1^WT^                                        [@R67], Molecular Cell                      N/A
  pQCXIP Flag-TIN2^A110R^                                           [@R36], Cell Res.                           N/A
  pQCXIP Myc-mPOT1a and OB fold mutant mPOT1a^F62A^                 [@R90], Cell                                N/A
  pCDNA3.1 Myc-TRF2                                                 [@R14], NSMB                                N/A
  pEGFP-EXO1                                                        [@R82], Nature Comm.                        N/A
  pLenti V5-EXO1                                                    [@R82], Nature Comm.                        N/A
  Fucci mKO-CTD1                                                    [@R72], Cell                                N/A
  Fucci mAG-Geminin                                                 [@R72], Cell                                N/A
  pGEX4T1 Human N-Terminal, C-Terminal, WT and Claspin 3A mutant    [@R54], JBC                                 N/A
  pQCXIP HA-hClaspin WT and mutants                                 This paper                                  N/A
  pQCXIP HA-mClaspin WT and mutants                                 This paper                                  N/A
  pQCXIP HA-mPCNA                                                   This paper                                  N/A
  pCMV6 Myc-mPCNA                                                   Origene                                     RC209379
  pQCXIP Myc hDonson                                                This paper                                  N/A
  pEGFP-DONSON and disease mutants                                  [@R69]                                      N/A
  Flag-ATRIP                                                        Lee Zou (Harvard Medical School)            N/A
  pRetroSuper sh*Trf2*                                              [@R23]                                      N/A
  pMKO.1 sh*BRCA1*                                                  Xiaohua Wu (Scrips Research Institute)      N/A
  pRetroSuper sh*Parp1*                                             Madalena Tarsounas (University of Oxford)   N/A
  pRetroSuper sh*Ligase 3*                                          Madalena Tarsounas                          N/A
  pRetroSuper sh*Rad51*                                             Madalena Tarsounas                          N/A
  pGIPZ sh*Claspin*                                                 Zhenkun Lou (Mayo Clinic)                   N/A
  pGIPZ sh*Rad52*                                                   Ryan Jensen (Yale University)               V2LHS_171206
  V3LHS_376616                                                                                                  
  PlK.01 Lenti sh*Polq*                                             Agnel Sfeir (NYU)                           N/A
  PlK.01 Lenti sh*Ctip*                                             Sigma-Aldrich                               TRCN0000305376
  PlK.01 Lenti sh*Exo1*                                             Sigma-Aldrich                               TRCN0000218614
  TRCN0000238466                                                                                                
  TRCN0000238468                                                                                                
  PlK.01 Lenti sh*Claspin*                                          Sigma-Aldrich                               TRCN0000193573
  TRCN0000175992                                                                                                
  TRCN0000193398                                                                                                
  PlK.01 Lenti sh*Pcna*                                             Sigma-Aldrich                               TRCN0000294872
  TRCN0000294805                                                                                                
  TRCN0000287377                                                                                                
  PlK.01 Lenti sh*Donson*                                           Sigma-Aldrich                               TRCN0000377075
  TRCN0000249773                                                                                                
  TRCN0000201175                                                                                                
  PlK.01 Lenti sh*PCNA*                                             Sigma-Aldrich                               TRCN0000003862
  TRCN0000003864                                                                                                
  PlK.01 Lenti sh*DONSON*                                           Sigma-Aldrich                               TRCN0000275364
  TRCN0000275365                                                                                                
  TRCN0000275367                                                                                                
  Software and Algorithms                                                                                       
  GraphPad Prism Software (Version 7)                               San Diego, CA                               RRID:SCR_002798
  NIS-Elements BR (Verson3.2)                                       Nikon                                       RRID:SCR_002776
  Origin 7 software                                                 OriginLab                                   N/A
  ImageQuantTL                                                      GE Healthcare                               RRID:SCR_014246
  FlowJo                                                            FlowJo LLC                                  RRID:SCR_008520

###### Highlights

-   A-NHEJ repair of telomeres lacking POT1-TPP1 occurs independently of MRN

-   Without MRN, Claspin and DNA-PK~cs~ promote CHK1 phosphorylation and A-NHEJ repair

-   Claspin interacts with TRF2 and helps recruit EXO1 for telomere C-strand resection

-   Increased replication stress in tumors without POT1 stabilized by claspin
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